Makrofajlarda Neopterin ve IP-10 Üretimine İnterlökin-33’ün Etkileri
Abstract
Keywords
References
- 1. Zhang C, Yang M, Ericsson AC. Function of macrophages in disease: current understanding on molecular mechanisms. Front Immunol. 2021;12:620510.
- 2. Finlay CM, Cunningham KT, Doyle B, et al. IL-33-stimulated murine mast cells polarize alternatively activated macrophages, which suppress t cells that mediate experimental autoimmune encephalomyelitis. J Immunol. 2020;205:1909-1919.
- 3. Guo H, Bossila EA, Ma X, et al. Dual immune regulatory roles of interleukin-33 in pathological conditions. Cells. 2022;11:3237.
- 4. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479-490.
- 5. Cayrol C. IL-33, an alarmin of the il-1 family involved in allergic and non allergic inflammation: focus on the mechanisms of regulation of its activity. Cells. 2021;11:107.
- 6. Lang S, Li L, Wang X, et al. J. CXCL10/IP-10 Neutralization can ameliorate lipopolysaccharide-induced acute respiratory distress syndrome in rats. PLoS One. 2017;12:e0169100.
- 7. Makuch E, Jasyk I, Kula A, et al. IFNβ-Induced CXCL10 chemokine expression is regulated by pellino3 ligase in monocytes and macrophages. Int J Mol Sci. 2022;23:14915.
- 8. Watanabe T. Neopterin derivatives - a novel therapeutic target rather than biomarker for atherosclerosis and related diseases. Vasa. 2021;50:165-173.
Details
Primary Language
Turkish
Subjects
Pediatric Hematology and Oncology
Journal Section
Research Article
Authors
Cemalettin Aybay
0000-0002-1534-2770
Türkiye
Hüseyin Tutkak
0000-0003-4233-0991
Türkiye
Vedat Bulut
0000-0002-0508-2127
Türkiye
Publication Date
May 25, 2023
Submission Date
November 2, 2022
Acceptance Date
April 25, 2023
Published in Issue
Year 2023 Volume: 76 Number: 1